Logo image of CLFD

CLEARFIELD INC (CLFD) Stock Fundamental Analysis

NASDAQ:CLFD - Nasdaq - US18482P1030 - Common Stock - Currency: USD

38.01  -1.33 (-3.38%)

After market: 38.01 0 (0%)

Fundamental Rating

5

Overall CLFD gets a fundamental rating of 5 out of 10. We evaluated CLFD against 49 industry peers in the Communications Equipment industry. CLFD has a great financial health rating, but its profitability evaluates not so good. CLFD is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CLFD had negative earnings in the past year.
CLFD had a positive operating cash flow in the past year.
Of the past 5 years CLFD 4 years were profitable.
CLFD had a positive operating cash flow in each of the past 5 years.
CLFD Yearly Net Income VS EBIT VS OCF VS FCFCLFD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.60%, CLFD is in line with its industry, outperforming 57.14% of the companies in the same industry.
The Return On Equity of CLFD (-0.70%) is better than 61.22% of its industry peers.
Industry RankSector Rank
ROA -0.6%
ROE -0.7%
ROIC N/A
ROA(3y)8.92%
ROA(5y)10.11%
ROE(3y)13.09%
ROE(5y)13.53%
ROIC(3y)N/A
ROIC(5y)N/A
CLFD Yearly ROA, ROE, ROICCLFD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

CLFD has a worse Gross Margin (24.54%) than 81.63% of its industry peers.
CLFD's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CLFD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.4%
GM growth 5Y-14.74%
CLFD Yearly Profit, Operating, Gross MarginsCLFD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

9

2. Health

2.1 Basic Checks

CLFD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CLFD has less shares outstanding
Compared to 5 years ago, CLFD has more shares outstanding
The debt/assets ratio for CLFD has been reduced compared to a year ago.
CLFD Yearly Shares OutstandingCLFD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CLFD Yearly Total Debt VS Total AssetsCLFD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 8.69 indicates that CLFD is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 8.69, CLFD belongs to the best of the industry, outperforming 89.80% of the companies in the same industry.
The Debt to FCF ratio of CLFD is 0.42, which is an excellent value as it means it would take CLFD, only 0.42 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CLFD (0.42) is better than 81.63% of its industry peers.
CLFD has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.02, CLFD is doing good in the industry, outperforming 67.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.42
Altman-Z 8.69
ROIC/WACCN/A
WACC9.84%
CLFD Yearly LT Debt VS Equity VS FCFCLFD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CLFD has a Current Ratio of 6.76. This indicates that CLFD is financially healthy and has no problem in meeting its short term obligations.
CLFD has a better Current ratio (6.76) than 91.84% of its industry peers.
CLFD has a Quick Ratio of 4.92. This indicates that CLFD is financially healthy and has no problem in meeting its short term obligations.
CLFD's Quick ratio of 4.92 is amongst the best of the industry. CLFD outperforms 91.84% of its industry peers.
Industry RankSector Rank
Current Ratio 6.76
Quick Ratio 4.92
CLFD Yearly Current Assets VS Current LiabilitesCLFD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

CLFD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.00%, which is quite impressive.
The Revenue has decreased by -2.14% in the past year.
The Revenue has been growing by 14.42% on average over the past years. This is quite good.
EPS 1Y (TTM)44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%122.5%
Revenue 1Y (TTM)-2.14%
Revenue growth 3Y5.79%
Revenue growth 5Y14.42%
Sales Q2Q%27.79%

3.2 Future

CLFD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.74% yearly.
The Revenue is expected to grow by 13.15% on average over the next years. This is quite good.
EPS Next Y116.8%
EPS Next 2Y64.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.85%
Revenue Next 2Y13.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CLFD Yearly Revenue VS EstimatesCLFD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
CLFD Yearly EPS VS EstimatesCLFD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLFD. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 62.63, CLFD can be considered very expensive at the moment.
CLFD's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CLFD is more expensive than 61.22% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CLFD to the average of the S&P500 Index (22.13), we can say CLFD is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 62.63
CLFD Price Earnings VS Forward Price EarningsCLFD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

CLFD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CLFD is cheaper than 61.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.33
EV/EBITDA N/A
CLFD Per share dataCLFD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

CLFD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLFD's earnings are expected to grow with 64.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.74%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CLFD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEARFIELD INC

NASDAQ:CLFD (6/13/2025, 8:00:00 PM)

After market: 38.01 0 (0%)

38.01

-1.33 (-3.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners62.88%
Inst Owner Change-6.29%
Ins Owners7.45%
Ins Owner Change-1.38%
Market Cap525.68M
Analysts82
Price Target46.92 (23.44%)
Short Float %10.84%
Short Ratio9.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)102.81%
Min EPS beat(2)58.55%
Max EPS beat(2)147.06%
EPS beat(4)4
Avg EPS beat(4)90.82%
Min EPS beat(4)58.55%
Max EPS beat(4)147.06%
EPS beat(8)8
Avg EPS beat(8)90.93%
EPS beat(12)12
Avg EPS beat(12)67.19%
EPS beat(16)16
Avg EPS beat(16)61.09%
Revenue beat(2)1
Avg Revenue beat(2)8.63%
Min Revenue beat(2)-2.78%
Max Revenue beat(2)20.03%
Revenue beat(4)3
Avg Revenue beat(4)10.03%
Min Revenue beat(4)-2.78%
Max Revenue beat(4)20.03%
Revenue beat(8)6
Avg Revenue beat(8)10%
Revenue beat(12)9
Avg Revenue beat(12)11.36%
Revenue beat(16)13
Avg Revenue beat(16)13.18%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)186.96%
EPS NY rev (1m)0%
EPS NY rev (3m)145.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 62.63
P/S 2.95
P/FCF 29.33
P/OCF 18.89
P/B 1.98
P/tB 2.07
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)0.61
Fwd EY1.6%
FCF(TTM)1.3
FCFY3.41%
OCF(TTM)2.01
OCFY5.29%
SpS12.89
BVpS19.23
TBVpS18.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.6%
ROE -0.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.54%
FCFM 10.06%
ROA(3y)8.92%
ROA(5y)10.11%
ROE(3y)13.09%
ROE(5y)13.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.4%
GM growth 5Y-14.74%
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.42
Debt/EBITDA N/A
Cap/Depr 131.13%
Cap/Sales 5.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.76
Quick Ratio 4.92
Altman-Z 8.69
F-Score6
WACC9.84%
ROIC/WACCN/A
Cap/Depr(3y)178.64%
Cap/Depr(5y)139.97%
Cap/Sales(3y)4.08%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%122.5%
EPS Next Y116.8%
EPS Next 2Y64.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.14%
Revenue growth 3Y5.79%
Revenue growth 5Y14.42%
Sales Q2Q%27.79%
Revenue Next Year11.85%
Revenue Next 2Y13.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year136.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.67%
FCF growth 3Y12.66%
FCF growth 5Y0.7%
OCF growth 1Y24.1%
OCF growth 3Y26.8%
OCF growth 5Y8.57%